Palantir Technologies delivered growth that would make most software companies weep. Seventy percent year-over-year revenue expansion. US commercial revenue jumping over 100% in stretches. Guidance raised to $7.2 billion. Yet the stock still got eviscerated, dropping 40% since November's $207.52 peak, now limping around $122-126.
The contradiction cuts at something deeper than typical market volatility. On paper, Palantir looks bulletproof. Foundry, the company's flagship platform, has wormed its way into healthcare, manufacturing, and government operations. A July partnership with Nvidia on secure AI offerings kept the momentum going. The State Department added Palantir to its Freedom Tech Excellence Program. By every operational metric, CEO Alex Karp's shop is crushing it.
The Math That Stopped Working
Here's where the story gets uncomfortable. Back in November, investors were willing to pay 250 times forward earnings for Palantir's promise. That number made sense when interest rates were where everyone thought they'd go. But then the Fed kept rates higher for longer, and suddenly future dollars became worth way less in present-value terms. A profit stream projected five years out loses its glitter fast when discount rates spike.
The company even touched $106.37 in June, a gut-wrenching 49% cliff from November to June low. That's not earnings disappointment talking. That's a sector-wide reckoning with valuation. Software stocks generally got smacked as investors rotated into names trading at more reasonable multiples.
Why Fundamentals Can't Save You in These Markets
Palantir's problem isn't that the business broke. It's that the machine pricing its future cash flows recalibrated overnight. When you're valued almost entirely on where you'll be in 2030, higher rates don't just trim a few percentage points off your multiple. They reset the whole equation.
Even now, Palantir trades at a premium to the broader software sector. But that gap has narrowed considerably from the absurd multiples of late 2025. The stock is working through a long, painful adjustment where growth alone can't paper over expensive entry points.
This article is informational only and should not be construed as financial advice. Investment decisions should be made based on your own research and risk tolerance.
